Skip to main content
. 2018 Mar 8;8(8):2161–2170. doi: 10.7150/thno.23335

Figure 5.

Figure 5

Blood clearance of dual-labeled girentuximab over seven days after injection (p.i.) fitted to a two-compartment model. Inset: clearance during the first three hours is depicted in more detail. Values are expressed as mean ± SD of 14 patients, since pharmacokinetic data of patient #3 were incomplete.

HHS Vulnerability Disclosure